INNV Net Income Growth
93.80%TTM
Period ending:
INNV TTM Net Income YoY %%
253.62%-992.70%
2021-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
INNV net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 93.798% | |
| 28.9035% | |
| 83.9958% | |
| -75.1425% | |
| -91.7049% | |
| -1.3403% | |
| 18.4454% | |
| 57.8857% | |
| 47.5377% | |
| 26.9873% | |
| 17.8091% | |
| -38.9443% | |
| -523.7234% | |
| -433.3202% | |
| -872.0893% | |
| -304.2681% | |
| 85.1745% | |
| 133.0066% | |
| 125.2257% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All INNV financial metrics · INNV stock overview · How to interpret financial metrics
